You are here

Hepatitis C treatment for injecting drug users
Year: 
2015
Go to Website

Perspectives on drugs: Hepatitis C Treatment for Injecting Drug Users

by
European Monitoring Centre for Drugs and Drug Addiction

Transmitted through the sharing of needles, syringes and other injecting equipment, hepatitis C is the most common infectious disease among injecting drug users in Europe today.In this analysis, the EMCDDA looks at some of the positive advances in treating the disease, including a new generation of medicines.

Part of the ‘Perspectives on drugs’ (PODs) series, launched alongside the annual European Drug Report, these designed-for-the-web interactive analyses aim to provide deeper insights into a selection of important issues.

  • Health care professionals
  • People who use drugs (PUD)
  • Policy makers
  • Central Europe
  • Northern Europe
  • Southern Europe
  • Western Europe
  • Care and support
  • Harm reduction
  • Prevention
  • Treatment
  • Viral hepatitis

Twitter News

Подписаться на рассылку